Publikationen in Zusammenarbeit mit Forschern von Hospital Virgen de la Arrixaca (6)

2018

  1. Correction to "Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition" [Oncotarget. 2017; 8:31959-31976]. Doi: https://doi.org/10.18632/oncotarget.16657

    Oncotarget

2016

  1. Report From the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External Quality Control for Natural Killer Alloreactive Donor Selection in Haploidentical Stem Cell Transplantation

    Transplantation Proceedings

2013

  1. Reunión anual del Grupo Español de trabajo en histocompatibilidad e inmunología del trasplante 2012. Estandarización de informes clínicos de sensibilización por anticuerpos anti-antígeno leucocitario humano

    Inmunologia

2007

  1. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection

    American Journal of Transplantation, Vol. 7, Núm. 7, pp. 1842-1848

2006

  1. Post-transplant soluble MICA and MICA antibodies predict subsequent heart graft outcome

    Transplant Immunology, Vol. 17, Núm. 1, pp. 43-46

  2. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection

    Transplantation, Vol. 82, Núm. 3, pp. 354-361